Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

A recently approved twice-yearly injection to prevent HIV may warrant a higher price, but thousands of dollars more?  CVS Caremark’s chief medical officer calls on Gilead Sciences to lower the $28,000 ...

The United States Food and Drug Administration has approved lenacapavir, an injectable drug that offers long-lasting protection against HIV infection. Administered once every six months, this new ...

(CNN) — A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of ...

Health Minister Dr Aaron Motsoaledi announced that the national rollout is expected to begin by March or April 2026, ...

HIV prevention drug Lenacapavir, which has been tested in South Africa during clinical trials, will be made available in the ...

Dr Joel Steingo of TB HIV Care says Lenacapavir could be a breakthrough in reducing infections, especially at a time when ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Only two people taking twice-yearly lenacapavir in a ...

Jessica Haberer has been a consultant for Merck and the US Centers for Disease Control and Prevention. She has been an investigator in studies with drug donation from Gilead and Viiv. She has received ...

The Food and Drug Administration on Wednesday approved Gilead's twice-yearly antiviral injection for preventing HIV — a milestone that the company and some experts say could help bring the world ...